<DOC>
	<DOCNO>NCT01931358</DOCNO>
	<brief_summary>The primary purpose study well define relative contribution AIDSVAX® B/E alone , ALVAC-HIV alone , ALVAC-HIV plus AIDSVAX® B/E combination observe immune profile week month receive original prime boost vaccine regimen study protocol RV 144 , booster effect systemic mucosal compartment . In addition , study provide intensive comprehensive characterization innate , cell-mediated humoral immune response possible within RV 144 study .</brief_summary>
	<brief_title>Study Boosting Strategies After Vaccination With ALVAC-HIV AIDSVAX® B/E</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>1 . Healthy , HIVuninfected male female volunteer age 20 40 , weigh 45 kilogram , available period 24 month Thai identity card . 2 . Must low risk HIV infection per investigator assessment . 3 . Must able understand complete inform consent process . 4 . Must capable reading Thai . 5 . Must successfully complete Test Understanding prior enrollment . 6 . Must good general health without clinically significant medical history . 7 . HIVuninfected per diagnostic algorithm within 45 day enrollment . 8 . Laboratory screen analysis : Hemoglobin : Women ≥12.0 g/dL , Men ≥12.5 g/dL White cell count : 4,000 11,000 cells/mm^3 Platelets : 150,000 450,000/mm^3 ALT AST ≤1.25 institutional upper limit reference range Creatinine : ≤1.25 institutional upper limit reference range Urinalysis ( dipstick ) blood protein great 1+ negative glucose . 9 . FemaleSpecific Criteria : Negative pregnancy test woman screen prior vaccination ( day ) prior invasive procedure . Be use adequate birth control method 45 day prior first vaccine/placebo vaccination least 3 month final vaccine/placebo vaccination . Adequate birth control define follow : Contraceptive medication deliver orally , intramuscularly , vaginally , implant , underneath skin , surgical method ( hysterectomy bilateral tubal ligation ) , condom , diaphragm , intrauterine device ( IUD ) , abstinence . 1 . Asplenia : condition result absence functional spleen . 2 . Bleeding disorder diagnose medical doctor ( e.g. , factor deficiency , coagulopathy , platelet disorder require special precaution ) . 3 . Therapeutic anticoagulation result abnormal prothrombin ( PT ) / international normalized ration ( INR ) partial prothrombin time ( PTT ) . 4 . Women breastfeed pregnant ( positive pregnancy test ) planning become pregnant window study enrollment 3 month last vaccination visit . 5 . History anaphylaxis serious adverse reaction vaccine allergy reaction likely exacerbate component vaccine placebo , include egg , egg product , streptomycin , neomycin . 6 . Subject receive following substance : Chronic use therapy may modify immune response , IV immuneglobulin systemic corticosteroid ( dos &gt; 20 mg/day prednisone equivalent period exceed 10 day ) . The following exception permit exclude study participation : use corticosteroid nasal spray rhinitis , topical corticosteroid acute uncomplicated dermatitis ; short course ( duration 10 day less , single injection ) corticosteroid nonchronic condition ( base investigator clinical judgment ) least 2 week prior enrollment study . Blood product within 120 day prior HIV screen . Immunoglobulins within 30 day prior HIV screen . Any licensed vaccine within 14 day prior initial study vaccine administration present study . Receipt investigational HIV vaccine . Investigational research agent vaccine within 30 day prior enrollment present study . Antituberculosis prophylaxis therapy past 90 day prior enrollment . 7 . Active sexually transmit infection confirm clinical exam diagnostic test . 8 . Any medical , psychiatric , social condition , occupational reason , responsibility , judgment investigator , contradiction protocol compliance impairs subject 's ability give inform consent . 9 . Psychiatric condition precludes compliance protocol ; past present psychosis ; past present bipolar disorder ; disorder require lithium ; within 5 year prior enrollment , history suicide ideation attempt . 10 . Study site employee involve protocol and/or may direct access study related area .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>